CA-GUESS?
27.7.2022 17:02:14 CEST | Business Wire | Press release
In collaboration with Homeboy Industries, GUESS has developed a unique process to give new life to old clothing. By transforming recycled pieces into fun, fashionable creations, GUESS is building a new pathway to being fabulously sustainable. Sustainability is at the heart of all that GUESS does, and the Company’s partnership with the non‐profit Homeboy Industries represents this commitment.
GUESS will work directly with Homeboy Recycling, a social enterprise branch of Homeboy Industries on the new Upcycled Collection. In partnering with GUESS, Homeboy Recycling has expanded from exclusively electronics recycling into the world of textiles and apparel. GUESS and Homeboy Recycling have created not only a remarkable new line of goods and apparel, but a new way to support environmental sustainability, facilitate creativity, create new jobs, and uplift our community: upcycled with a whole lot of heart.
It is with absolute pride that GUESS announces the Upcycled Collection. A collection unlike any other, because no two pieces are alike. Transforming recycled clothing yields distinctly unique pieces, and that is its ultimate appeal. Tote bags, patchwork denim, bustiers, and even throw pillows; upcycled fashion for everyone. The Upcycled Collection is a sustainable, fashionable, purposeful way to shop‐the truest form of circular fashion.
“Homeboy Industries is grateful for the partnership with GUESS for the Upcycled Collection. We thank GUESS for supporting our mission to provide hope, training, and support to this marginalized population, allowing them to change the arc of their lives and become contributing members of the community. Homeboy Industries provides comprehensive trauma‐informed, wrap‐around support services such as tattoo removal, mental health services, education, legal, housing navigation, case management, workforce development, and job training,” says Chris Zwicke, CEO of Homeboy Industries. “Through this partnership, our employees at our fastest growing social enterprise, Homeboy Recycling, will gain more job skills and training, which we are very excited about.”
“The Upcycled Collection in collaboration with Homeboy Industries is designed with the hope that each piece can give purpose to a member of the community who can learn the skills needed to turn discarded merchandise into desirable, commodified items with an eye to the fashion set. The designs are determined by the resources at hand, which are carefully organized and sorted. The product range is fashion to non‐fashion pieces, so there is something for everyone. And the true joy is the wonderment around the former life of each piece and how it came to be,” says Amy Enuke, Young Contemporary Design Director.
With GUESS’ commitment to circular fashion and Homeboy Recycling’s foundation of sustainability, this partnership is the launching pad for a new kind of sustainable fashion—one that not only supports the environment but also directly supports our communities. To learn more about GUESS’ commitment to our planet, visit guess.com/sustainability
About GUESS?, Inc.
Established in 1981, GUESS began as a jeans company and has since successfully grown into a global lifestyle brand. Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. As of April 30, 2022, the Company directly operated 1,073 retail stores in the Americas, Europe and Asia. The Company’s partners and distributors operated 565 additional retail stores worldwide. As of April 30, 2022, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com.
About Homeboy Recycling
Homeboy Recycling is a certified and award-winning social enterprise offering nationwide services for the proper disposal and management of IT assets. As one of the few R2 (Responsible Recycling) and B Corp certified companies in the world, Homeboy is committed to the highest possible standards for electronics reuse, e-waste recycling and the destruction of sensitive data. Each year, Homeboy refurbishes thousands of computers and diverts millions of pounds of electronics away from the landfill while creating jobs for people facing systemic barriers to employment. Beyond our IT asset disposition and e-waste services, we see ourselves broadly as a partner in the circular economy. We work with committed manufacturers and brands to develop socially and environmentally beneficial solutions for their products after their first life. In this capacity, we are expanding our services to include apparel/textiles and other products/materials that fit our mission.
As part of Homeboy Industries, the world’s preeminent gang rehabilitation and re-entry program, Homeboy Recycling proudly employs people committed to transforming their lives after incarceration. For more information, visit https://homeboyrecycling.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005664/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom